TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has provided an announcement.
ASKA Pharmaceutical Holdings Co., Ltd. has established an Independent Committee to enhance the fairness and objectivity of its response policies concerning large-scale purchases of company shares by entities such as Dalton Investments. The committee, composed of independent outside directors, will provide recommendations to the board of directors, ensuring transparency and protecting shareholder interests.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is headquartered in Minato-ku, Tokyo, and is led by President and Representative Director Sohta Yamaguchi.
Average Trading Volume: 43,591
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen64.64B
For an in-depth examination of 4886 stock, go to TipRanks’ Overview page.